Astellas Pharma Inc. and FibroGen, Inc. has announced the submission of a supplemental New Drug Application (sNDA) to&nb...
Headquartered in Australia, Noxopharm Limited is a clinical stage drug development company that has been in the limeligh...
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, introduced new workstations...
US based Inovio Pharmaceuticals, has announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded In...
The Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for darolutamide, under th...
US based RegeneRx Biopharmaceuticals, a clinical-stage drug development company focused on tissue protection, repai...
Hitachi Chemical Advanced Therapeutics Solutions, LLC, a US subsidiary of Japanese firm Hitachi Chemical Co., Ltd....
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease target...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as share...
US based InterVenn Biosciences has announced multiple achievements in its development of AI-enabled glycoproteomics, as ...
US based company Charles River has announced a multi-year drug discovery collaboration with Japanese firm Takeda Pharmac...
apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manu...
Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplem...
AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of a...
Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for In...
AstraZeneca has announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintena...
China based Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Adminis...
Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU®...
